Interval Partners’s Colgate-Palmolive CL Stock Holding History

Interval Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.02M	Buy	+54,800	New	+$4.79M	0.13%	182

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Interval Partners's CL Position: Q1 2023 in Review

Interval Partners sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 234,216 shares — an estimated $18.5M sold.

Interval Partners first reported a position in CL in Q2 2022 and held it in 3 quarters. The position peaked at $36.9M in Q3 2022. 1,656 funds tracked by Wall St. Rank hold CL as of Q1 2023.

Interval Partners reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
Interval Partners sold 234,216 Colgate-Palmolive shares in Q1 2023, an estimated $18.5M.
Interval Partners first reported a position in Colgate-Palmolive in Q2 2022 and held it in 3 quarters.
Interval Partners's Colgate-Palmolive position peaked at $36.9M in Q3 2022.
1,656 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on Interval Partners's 13F filing for Q1 2023, filed 15 May 2023.